Hildebran-Icard Family Med Cr is categorized under Family Practice Doctors in Hildebran, NC .
Hildebran-Icard Family Med Cr was established in 0, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Family Practice Doctors business, which does work in the B2C market, and is classified as a Family Practice Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Lisa Queen at the company’s single location by writing to 517 Main Avenue West, Hildebran, North Carolina NC 28637 or by phoning (828) 580-5561. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Hildebran-Icard Family Med Cr |
Contact Person: | Lisa Queen |
Address: | 517 Main Avenue West, Hildebran, North Carolina 28637 |
Phone Number: | (828) 580-5561 |
Website Address: | blueridgehealth.org |
Annual Revenue (USD): | $500.000 to $999.999 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Family Practice Doctors |
SIC Code: | 8011 |
NAICS Code: | 6211110 |
Share This Business: |
Hildebran-Icard Family Med Cr was started in 0 to provide professional Family Practice Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Lisa Queen for inquiries that concern Hildebran-Icard Family Med Cr by calling the company number (828) 580-5561, as your correspondence is most welcome. Additionally, the physical location of the single location of Hildebran-Icard Family Med Cr can be found at the coordinates 35.71086,-81.43398 as well as the street address 517 Main Avenue West in Hildebran, North Carolina 28637.
For its online presence, you may visit Hildebran-Icard Family Med Cr’s website at blueridgehealth.org and engage with its social media outlets through on Twitter and on Facebook.